- Conditions
- Bladder Function
- Interventions
- cystometry (CMG), polysomnography (PSG)
- Procedure
- Lead sponsor
- Astellas Pharma Inc
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 62
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Interstitial Cystitis, Chronic Interstitial Cystitis, Bladder Pain Syndrome
- Interventions
- Pulsed Electromagnetic Field (PEMF) Therapy
- Device
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years to 80 Years · Female only
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Winston-Salem, North Carolina
- Conditions
- Pelvic Floor Disorders, Anxiety, Urinary Urgency, Urinary Incontinence, Nocturia, Urinary Frequency/Urgency, Lower Urinary Tract Symptoms, Urinary Hesitancy, Urinary Straining
- Interventions
- Unified Protocol, Supportive Therapy
- Behavioral
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 38 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Nocturia, Insomnia
- Interventions
- Integrated Behavioral Therapy Program, Health Education Program
- Behavioral
- Lead sponsor
- Atlanta VA Medical Center
- Federal
- Eligibility
- 60 Years and older
- Enrollment
- 192 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2028
- U.S. locations
- 2
- States / cities
- Los Angeles, California • Atlanta, Georgia
- Conditions
- BPH, Prostate Hyperplasia, Urinary Frequency/Urgency
- Interventions
- MRI Guided Transrectal Periuretheral Transitional Zone Ablation
- Device
- Lead sponsor
- Prostate Laser Center, PLLC
- Industry
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 10 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2020
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Urinary Incontinence
- Interventions
- tolterodine
- Drug
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 45 Years to 65 Years · Female only
- Enrollment
- 19 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2011
- U.S. locations
- 2
- States / cities
- Boston, Massachusetts
- Conditions
- Urgency Urinary Incontinence, Nocturia
- Interventions
- Mirabegron 50 MG, Brief Behavioral Treatment for Insomnia
- Drug · Behavioral
- Lead sponsor
- Shachi Tyagi
- Other
- Eligibility
- 60 Years and older · Female only
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Nocturia, Daytime Sleepiness
- Interventions
- Armodafinil, Placebo
- Drug
- Lead sponsor
- Duke University
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 81 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2015
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Overactive Bladder
- Interventions
- Tolterodine tartrate extended release capsules, Desmopressin orally disintegrating tablets, Placebo orally disintegrating tablets
- Drug
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 106 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 24
- States / cities
- Jonesboro, Arkansas • Little Rock, Arkansas • Los Angeles, California + 19 more
- Conditions
- Nocturia
- Interventions
- Placebo, Paxerol - Dose Level 1, Paxerol - Dose Level 2, Paxerol - Dose Level 3
- Other · Drug
- Lead sponsor
- Wellesley Pharmaceuticals, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 86 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 4
- States / cities
- Brooklyn, New York • Harrison, New York • New York, New York
- Conditions
- Nocturia
- Interventions
- VA106483
- Drug
- Lead sponsor
- Vantia Ltd
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 152 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 19
- States / cities
- Birmingham, Alabama • Tucson, Arizona • Los Angeles, California + 16 more
- Conditions
- Nocturia
- Interventions
- Fedovapagon 2 mg, Placebo
- Drug
- Lead sponsor
- Vantia Ltd
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 432 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 48
- States / cities
- Anniston, Alabama • Goodyear, Arizona • Lincoln, California + 45 more
- Conditions
- Nocturia
- Interventions
- VA106483, Placebo
- Drug · Other
- Lead sponsor
- Vantia Ltd
- Industry
- Eligibility
- 40 Years and older · Female only
- Enrollment
- 21 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010
- U.S. locations
- 1
- States / cities
- Overland Park, Kansas
- Conditions
- Urinary Incontinence
- Interventions
- PureWick System, UltraFlex Self-Adhering Male External Catheter
- Device
- Lead sponsor
- C. R. Bard
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 15
- States / cities
- Guntersville, Alabama • Tucson, Arizona • Los Angeles, California + 11 more
- Conditions
- Nocturia
- Interventions
- Desmopressin, Placebo
- Drug
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 56 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012
- U.S. locations
- 10
- States / cities
- Aventura, Florida • DeLand, Florida • Peoria, Illinois + 6 more
- Conditions
- Nocturia
- Interventions
- desmopressin acetate, Placebo
- Drug
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 799 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 70
- States / cities
- Birmingham, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 59 more
- Conditions
- Nocturia
- Interventions
- SER120 750 ng, SER120 1500 ng, Placebo
- Drug
- Lead sponsor
- Serenity Pharmaceuticals, Inc.
- Industry
- Eligibility
- 50 Years to 95 Years
- Enrollment
- 810 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- Newport Beach, California
- Conditions
- Overactive Bladder, Urge Incontinence, Urinary Incontinence, Urinary Frequency More Than Once at Night
- Interventions
- Zida
- Device
- Lead sponsor
- Exodus Innovations
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020
- U.S. locations
- 1
- States / cities
- Coral Gables, Florida
- Conditions
- Nocturia, Prostatic Hyperplasia
- Interventions
- silodosin
- Drug
- Lead sponsor
- Watson Pharmaceuticals
- Industry
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 215 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009
- U.S. locations
- 27
- States / cities
- Huntsville, Alabama • Laguna Hills, California • San Diego, California + 24 more
- Conditions
- Survivorship, Prostate Cancer
- Interventions
- Acupuncture, Waitlist Control, Questionnaires
- Procedure · Other
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 8
- States / cities
- Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more
- Conditions
- Nocturia
- Interventions
- Behavioral, tamsulosin (alpha-adrenergic antagonist medication), placebo, placebo
- Behavioral · Drug
- Lead sponsor
- Atlanta VA Medical Center
- Federal
- Eligibility
- 40 Years and older · Male only
- Enrollment
- 72 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2014
- U.S. locations
- 2
- States / cities
- Birmingham, Alabama • Atlanta, Georgia
- Conditions
- Overactive Bladder, Parkinson Disease
- Interventions
- solifenacin, Pelvic floor muscle exercise-based behavioral therapy
- Drug · Behavioral
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- Not listed
- Enrollment
- 77 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2023
- U.S. locations
- 4
- States / cities
- Birmingham, Alabama • Decatur, Georgia • Philadelphia, Pennsylvania + 1 more
- Conditions
- Urinary Frequency, Urinary Urgency, Nocturia
- Interventions
- Solifenacin PO
- Drug
- Lead sponsor
- Seattle Urology Research Center
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 23 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2007
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Nocturia
- Interventions
- SER120 (750 ng/day), SER120 (1000 ng/day), SER120 (1500 ng/day), Placebo
- Drug
- Lead sponsor
- Serenity Pharmaceuticals, Inc.
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 750 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 1
- States / cities
- New City, New York